Evofem Biosciences
Evofem Biosciences develops and commercializes products focused on women's sexual and reproductive health. Its flagship product, Phexxi, is a hormone-free vaginal gel approved in the U.S. for pregnancy prevention.
Top Regions
Top Stages
1 past transactions
Neothetics
Acquisition in 2018
Neothetics, Inc. was a clinical-stage specialty pharmaceutical company focused on developing therapeutics for the aesthetic market. Founded in 2007 and headquartered in San Diego, California, the company specialized in innovative treatments aimed at improving aesthetic outcomes. Its lead product candidate, LIPO-202, was an injectable formulation designed to reduce localized fat deposits under the chin and address central abdominal bulging in non-obese patients. Originally established as Lipothera, Inc., the company underwent a name change in August 2014, reflecting its commitment to aesthetic medicine. Neothetics was acquired by Evofem Biosciences, Inc. in a reverse merger transaction in January 2018.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.